ISPOR “ON THE ROAD” IN 1ST QUARTER 2016

Published Apr 5, 2016
ANNOUNCEMENT

 ISPOR “ON THE ROAD” IN 1ST QUARTER 2016 

Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) attended a number of industry meetings during the first quarter of 2016. The following is a sampling of ISPOR’s meeting activity.  EUnetHTA Joint Action 3 Kick-Off Meeting The European Network for Health Technology Assessment (EUnetHTA) held its Joint Action 3 (JA3) kick-off meeting on March 3, 2016. EUnetHTA JA3 will begin its activities in the near future with the objective to increase the use, quality, and efficiency of joint HTA work at the European level. ISPOR’s CEO, Nancy Berg, and Senior Director of Scientific and Health Policy Initiatives, Nadia Naaman, attended the meeting. Patients as Partners Conference ISPOR’s Manager of Scientific and Health Policy Initiatives, Theresa Tesoro, MSN, attended the 3rd Annual Patients as Partners Conference held in Philadelphia, PA, USA on March 2-3, 2016. Attendance of this conference helps to support development of ISPOR’s patient initiatives.   FDAMA 114 Discussion Meeting ISPOR President, Daniel C. Malone, RPh, PhD, attended and participated in the panel of the Food and Drug Administration Modernization Act (FDAMA) Section 114 discussion meeting in Washington, DC, USA this March. ISPOR’s Strategic Plan pillar focused on Scientific and Research Excellence calls for ISPOR to act as an educational resource to policy-makers, such as FDA. Pan American Health Organization (PAHO) Discussion ISPOR CEO, Nancy Berg, attended discussions at the PAHO Washington, DC, USA office. Relationships with organizations that have similar interests, such as PAHO, support ISPOR’s Strategic Plan pillar focused on Communication and Collaboration.   For additional information, please contact Betsy Lane, director, chief marketing and communications officer at BLane@ispor.org or 609-586-4981 x112.

###

Related Stories

ISPOR Publishes Insights From Its First Global HTA Roundtable

Apr 21, 2025

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) published the insights from its first Global Health Technology Assessment (HTA) Roundtable in an article in the March/April issue of Value & Outcomes Spotlight.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.

ISPOR Celebrates Its 30-Year Anniversary

Mar 24, 2025

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it is celebrating its 30th anniversary in 2025.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×